Cargando…
Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
OBJECTIVE: To investigate the nature of prodromal headache in anti‐NMDA receptor (NMDAR) encephalitis. METHODS: Retrospective review of the clinical information of 39 patients with anti‐NMDAR encephalitis admitted between January 1999 and September 2017. Five patients with an atypical presentation w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043713/ https://www.ncbi.nlm.nih.gov/pubmed/29856136 http://dx.doi.org/10.1002/brb3.1012 |
_version_ | 1783339340038930432 |
---|---|
author | Tominaga, Naomi Kanazawa, Naomi Kaneko, Atsushi Kaneko, Juntaro Kitamura, Eiji Nakagawa, Hiroto Nishiyama, Kazutoshi Iizuka, Takahiro |
author_facet | Tominaga, Naomi Kanazawa, Naomi Kaneko, Atsushi Kaneko, Juntaro Kitamura, Eiji Nakagawa, Hiroto Nishiyama, Kazutoshi Iizuka, Takahiro |
author_sort | Tominaga, Naomi |
collection | PubMed |
description | OBJECTIVE: To investigate the nature of prodromal headache in anti‐NMDA receptor (NMDAR) encephalitis. METHODS: Retrospective review of the clinical information of 39 patients with anti‐NMDAR encephalitis admitted between January 1999 and September 2017. Five patients with an atypical presentation were excluded. Thus, in 34 patients (median 27 years [range, 12–47 years]; 28 [82%] female), the clinical features were compared between patients who initially reported headache and those who did not report. RESULTS: Twenty‐two patients (65%) reported headache either transiently (n = 5) or continuously (n = 17). Encephalitic symptoms (psychobehavioral memory alterations, seizure, dyskinesias, or altered level of consciousness) developed in 20 patients with median 5.5 days (range, 1‐29 days) after headache onset. In one patient, NMDAR antibodies were detected in CSF 3 days after headache onset. Patients with headache had more frequently fever (14/22 [64%] vs. 2/12 [17%] p = 0.013) and higher CSF pleocytosis (median white blood cells 79/μl [range, 6‐311/μl] vs. 30/μl [range, 2‐69/μl], p = 0.035) than those without headache, but there was no difference in gender, age at onset, seizure, migraine, CSF oligoclonal band detection, elevated IgG index, tumor association, or brain MRI abnormalities between them. CONCLUSIONS: Headache often developed with fever and pleocytosis, but it was rapidly replaced by psychiatric symptoms. Based on current knowledge on the antibody‐mediated mechanisms that cause a decrease of synaptic NMDAR through crosslinking and internalization leading to a state mimicking “dissociative anesthesia,” we speculated that prodromal headache is not likely caused by direct effect of the autoantibodies but rather meningeal inflammation (noninfectious aseptic meningitis) that occurs in parallel to intrathecal antibody synthesis as an epiphenomenon of NMDAR autoimmunity. Psychobehavioral alterations following headache is an important clue to the diagnosis. |
format | Online Article Text |
id | pubmed-6043713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60437132018-07-15 Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity Tominaga, Naomi Kanazawa, Naomi Kaneko, Atsushi Kaneko, Juntaro Kitamura, Eiji Nakagawa, Hiroto Nishiyama, Kazutoshi Iizuka, Takahiro Brain Behav Original Research OBJECTIVE: To investigate the nature of prodromal headache in anti‐NMDA receptor (NMDAR) encephalitis. METHODS: Retrospective review of the clinical information of 39 patients with anti‐NMDAR encephalitis admitted between January 1999 and September 2017. Five patients with an atypical presentation were excluded. Thus, in 34 patients (median 27 years [range, 12–47 years]; 28 [82%] female), the clinical features were compared between patients who initially reported headache and those who did not report. RESULTS: Twenty‐two patients (65%) reported headache either transiently (n = 5) or continuously (n = 17). Encephalitic symptoms (psychobehavioral memory alterations, seizure, dyskinesias, or altered level of consciousness) developed in 20 patients with median 5.5 days (range, 1‐29 days) after headache onset. In one patient, NMDAR antibodies were detected in CSF 3 days after headache onset. Patients with headache had more frequently fever (14/22 [64%] vs. 2/12 [17%] p = 0.013) and higher CSF pleocytosis (median white blood cells 79/μl [range, 6‐311/μl] vs. 30/μl [range, 2‐69/μl], p = 0.035) than those without headache, but there was no difference in gender, age at onset, seizure, migraine, CSF oligoclonal band detection, elevated IgG index, tumor association, or brain MRI abnormalities between them. CONCLUSIONS: Headache often developed with fever and pleocytosis, but it was rapidly replaced by psychiatric symptoms. Based on current knowledge on the antibody‐mediated mechanisms that cause a decrease of synaptic NMDAR through crosslinking and internalization leading to a state mimicking “dissociative anesthesia,” we speculated that prodromal headache is not likely caused by direct effect of the autoantibodies but rather meningeal inflammation (noninfectious aseptic meningitis) that occurs in parallel to intrathecal antibody synthesis as an epiphenomenon of NMDAR autoimmunity. Psychobehavioral alterations following headache is an important clue to the diagnosis. John Wiley and Sons Inc. 2018-06-01 /pmc/articles/PMC6043713/ /pubmed/29856136 http://dx.doi.org/10.1002/brb3.1012 Text en © 2018 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Tominaga, Naomi Kanazawa, Naomi Kaneko, Atsushi Kaneko, Juntaro Kitamura, Eiji Nakagawa, Hiroto Nishiyama, Kazutoshi Iizuka, Takahiro Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity |
title | Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity |
title_full | Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity |
title_fullStr | Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity |
title_full_unstemmed | Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity |
title_short | Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity |
title_sort | prodromal headache in anti‐nmdar encephalitis: an epiphenomenon of nmdar autoimmunity |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043713/ https://www.ncbi.nlm.nih.gov/pubmed/29856136 http://dx.doi.org/10.1002/brb3.1012 |
work_keys_str_mv | AT tominaganaomi prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT kanazawanaomi prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT kanekoatsushi prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT kanekojuntaro prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT kitamuraeiji prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT nakagawahiroto prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT nishiyamakazutoshi prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity AT iizukatakahiro prodromalheadacheinantinmdarencephalitisanepiphenomenonofnmdarautoimmunity |